TerminatedPhase 2NCT01140191

Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: U.S. Army Medical Research and Development Command
Principal Investigator: Timothy Whitman, DO, USN
Walter Reed Army Medical Center
Intervention: WR 279,396(drug)
Enrollment: 1 enrolled
Eligibility: 18 years · All sexes
Timeline: 2013 – 2014

Study locations (1)

Walter Reed National Military Medical Center (WRNMMC), Bethesda, Maryland, United States

Collaborators

Walter Reed National Military Medical Center · Walter Reed Army Institute of Research (WRAIR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01140191 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials